COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma

DSpace Repository

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma

Author: Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline; Arance, Ana; de Groot, Jan Willem B.; Garbe, Claus; Gogas, Helen J.; Gutzmer, Ralf; Krajsova, Ivana; Liszkay, Gabriella; Loquai, Carmen; Mandala, Mario; Schadendorf, Dirk; Yamazaki, Naoya; di Pietro, Alessandra; Cantey-Kiser, Jean; Edwards, Michelle; Ascierto, Paolo A.
Tübinger Autor(en):
Garbe, Claus
Published in: Journal of Clinical Oncology (2022), Bd. 40, H. 36, S. 4178
Verlagsangabe: Philadelphia : Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1200/JCO.21.02659
ISSN: 0732-183X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)